ARCHIVES

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

NCI By Pass Budget For FY 1987 Is $1.57 Bil.

October 18, 1985

Intramural Program Downsizing Expected; Gallin Named Head of Clinical Center

April 15, 1994

Lung, Head & Neck Treatment Advances Reported At ASCO Annual Meeting

May 27, 1977

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011

NCI Prepares To Dispense A Torrent Of New Money For Cancer Research.

March 6, 2009

In Brief: Gift to Jefferson Funds Capizzi Professorship; Abrams Named Special Assistant to DDES

January 9, 1998